We are live on
!
Find out more
FAF
Fjarde Ap-fonden Portfolio holdings
AUM
$20.9B
1-Year Est. Return
36.93%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.35B
AUM Growth
-$265M
(-5.7%)
Cap. Flow
-$308M
Cap. Flow
% of AUM
-7.08%
Top 10 Holdings %
Top 10 Hldgs %
16.54%
Holding
629
New
5
Increased
18
Reduced
506
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.19M |
| 2 |
Medtronic
MDT
|
+$6.17M |
| 3 |
Qorvo
QRVO
|
+$3.05M |
| 4 |
Alkermes
ALKS
|
+$3M |
| 5 |
Comcast
CMCSA
|
+$2.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$15M |
| 2 |
Apple
AAPL
|
+$12.4M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$11M |
| 4 |
ExxonMobil
XOM
|
+$5.57M |
| 5 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$4.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.89% |
| 2 | Technology | 15.07% |
| 3 | Financials | 14.56% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$5.01T
| $165M | 3.79% |
5,298,348
-411,732
| -7% | -$12.4M |
|
|
2
ExxonMobil
XOM
$648B
| $81.1M | 1.86% |
954,204
-62,802
| -6% | -$5.57M |
|
3
Alphabet (Google) Class C
GOOG
$4.11T
| $71.5M | 1.64% |
2,599,297
-129,855
| -5% | -$3.48M |
|
4
Microsoft
MSFT
$2.94T
| $70.7M | 1.62% |
1,738,816
-97,498
| -5% | -$4.24M |
|
5
Johnson & Johnson
JNJ
$639B
| $63.6M | 1.46% |
631,733
-40,601
| -6% | -$4.13M |
|
6
Wells Fargo
WFC
$255B
| $61.2M | 1.41% |
1,125,404
-72,103
| -6% | -$3.9M |
|
7
GE Aerospace
GE
$366B
| $56.5M | 1.3% |
470,324
-28,895
| -6% | -$3.44M |
|
8
JPMorgan Chase
JPM
$919B
| $51.1M | 1.17% |
843,478
-53,240
| -6% | -$3.15M |
|
9
Pfizer
PFE
$143B
| $49.6M | 1.14% |
1,503,135
-89,441
| -6% | -$2.84M |
|
10
Procter & Gamble
PG
$337B
| $49.5M | 1.14% |
604,376
-41,140
| -6% | -$3.54M |
|
11
Verizon
VZ
$197B
| $45.4M | 1.04% |
934,234
-53,636
| -5% | -$2.59M |
|
12
Chevron
CVX
$381B
| $44.5M | 1.02% |
423,862
-28,801
| -6% | -$3.07M |
|
13
Walt Disney
DIS
$171B
| $38.4M | 0.88% |
365,788
-26,497
| -7% | -$2.67M |
|
14
AT&T
T
$164B
| $38.3M | 0.88% |
1,552,382
-83,715
| -5% | -$2.13M |
|
15
Merck
MRK
$321B
| $37.2M | 0.85% |
672,293
-48,061
| -7% | -$2.72M |
|
16
Meta Platforms (Facebook)
META
$1.5T
| $36.6M | 0.84% |
445,247
-16,981
| -4% | -$1.33M |
|
17
Bank of America
BAC
$429B
| $36.4M | 0.84% |
2,365,868
-140,597
| -6% | -$2.26M |
|
18
Coca-Cola
KO
$383B
| $35.8M | 0.82% |
882,310
-58,387
| -6% | -$2.44M |
|
19
Oracle
ORCL
$345B
| $35.4M | 0.81% |
820,537
-51,237
| -6% | -$2.22M |
|
20
Citigroup
C
$214B
| $35.1M | 0.81% |
681,887
-40,759
| -6% | -$2.08M |
|
21
IBM
IBM
$216B
| $34.2M | 0.79% |
223,159
-14,571
| -6% | -$2.21M |
|
22
Intel
INTC
$429B
| $34.1M | 0.78% |
1,090,566
-89,272
| -8% | -$3.01M |
|
23
Home Depot
HD
$339B
| $33.7M | 0.78% |
296,879
-23,767
| -7% | -$2.62M |
|
24
Gilead Sciences
GILD
$166B
| $33.5M | 0.77% |
341,055
-19,175
| -5% | -$1.95M |
|
25
Amazon
AMZN
$2.47T
| $33.4M | 0.77% |
1,794,520
-97,200
| -5% | -$1.71M |
|
Similar funds
MMH
VARA
SC
CB
MIC
GT
Fjarde Ap-fonden's Q1 2015 Portfolio in Review
As of Q1 2015, Fjarde Ap-fonden held 629 positions worth $4.35B, down 5.7% from $4.62B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fjarde Ap-fonden withdrew a net $308M in Q1 2015, closing 10 positions and reducing 506 holdings. Its most notable exit was Allergan Inc, an estimated $15M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, Fjarde Ap-fonden opened a new position in Qorvo worth $3.42M.
- Fjarde Ap-fonden's largest Q1 2015 buy was Qorvo: 42,872 shares worth $3.42M.
- Fjarde Ap-fonden added most to Allergan plc in Q1 2015, an estimated $6.19M increase.
- Fjarde Ap-fonden's biggest Q1 2015 reduction was Apple, cutting an estimated $12.4M.
- Fjarde Ap-fonden fully exited Allergan Inc in Q1 2015, selling an estimated $15M.
- Fjarde Ap-fonden's ten largest holdings make up 17% of its $4.35B portfolio in Q1 2015.
- Fjarde Ap-fonden opened 5 new positions and closed 10 in Q1 2015.
- Fjarde Ap-fonden's portfolio value fell 5.7% quarter-over-quarter to $4.35B.
Based on Fjarde Ap-fonden's 13F filing for Q1 2015, filed 13 Apr 2015.